Skip to content
ESPT
MARKETS / NYSE / Health care / Medical devices and instruments / RVP
NYSE · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP

Retractable Technologies Inc. RVP

17 fiscal years on record · USD · FY2025 reported · SEC filings only
$38.3M
▲ 15.8% YoY
$-12.6M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Our business is the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. We have manufacturing facilities in Little Elm, Texas and use manufacturers in China as well. Our dominant revenue-generating products are our injection devices (syringes and needles). We distribute our products throughout the U.S. through general line and specialty distributors. As of March 9, 2026, we had 201 employees.

Written from the business description in RETRACTABLE TECHNOLOGIES INC's annual report to the U.S. Securities and Exchange Commission, filed 27 March 2026. Every sentence was checked against that document before publication.

Growth

USD 38.3M
Revenue, FY2025 · full 17-year series below
Revenue $M Net income $M
FY2025 · Revenue 38.3 · Net income -12.6
100M200M
2009201220152018202120242025
Compound annual growth
−26.1%
−14.1%
+2.6%
+0.4%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −14.1% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−33 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -55.3% · Net -32.8%
10%20%30%-20%-40%-60%
200920172025
ROE
FY2025 · ROE -15.6%
20%40%60%-10%-20%
200920172025
Three returns, three denominators.
Gross margin0.1%
Operating margin-55.3%
Net margin-32.8%
EBITDAUSD -13.4M

Each USD of equity lost 16 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2024 · FCF -13.0
3M6M-10M-20M
200920172025
Net buybacks $M Dividends $M
FY2022 · Dividends · · Net buybacks 7.6
3M6M-1M-2M
2012201320212022
Dividends paid·
Net buybacks·
Share of profit·
Consecutive raises·

Total assetsUSD 142.6M
EquityUSD 74.4M
CashUSD 2.6M
Gross debtUSD 895,645.00
Net debtUSD -1.7M
Current ratio6.57×

The company holds more cash than debt.

The 17-year record

17 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
RVP, 17-year financial record
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B0.00.00.00.10.20.10.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.0−0.0−0.0−0.00.10.00.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.00.00.10.00.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Income tax $B0.00.0−0.00.00.00.00.0−0.0−0.00.00.00.00.00.00.0−0.0−0.0
Net income $B−0.0−0.0−0.00.00.10.00.0−0.0−0.0−0.00.0−0.0−0.0−0.00.00.0−0.0
Free cash flow $B◌−0.00.0−0.0−0.0−0.00.0−0.0−0.0−0.0−0.0−0.00.0−0.00.00.0−0.0
EPS, diluted $−0.43−0.40−0.240.151.630.800.07−0.06−0.14−0.150.20−0.12−0.26−0.190.020.04−0.45
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend—————————————————
ROE %−15.6−12.7−6.84.975.261.811.6−5.1−13.5−12.515.0−8.5−19.3−11.13.76.4−26.2
Shares out B0.030.030.030.030.030.030.030.030.030.030.030.030.030.030.030.02◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

MCK · COR · CAH · JNJ · HCA · LLY
Provenance

Company facts, as filed

How we verify · 0 failures in 83 reconciliationsAUDITED

Reconciled in 17 of the 17 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Two checks were skipped: EPS is not tagged before 2009. Two checks were skipped: revenue is not tagged before 2009.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNYSE
Incorporated inTexas
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2009

Share this section

Download image